Silk Road Medical IncChange company Symbol lookupSelect an option...SILK Silk Road Medical IncLYLT Loyalty Ventures IncBOXD Boxed IncALLR Allarity Therapeutics IncSIVB SVB Financial GroupNMRD Nemaura Medical IncLOGI Logitech International SABIOC Biocept IncKT KT CorpSVRA Savara IncGo
Silk Road Medical, Inc. is a medical device company, which is focused on reducing the risk of stroke and its devastating impact. The Company has discovered an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR), which relies on two concepts: minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain and combines the benefits of innovative endovascular techniques with fundamental surgical principles. The Company's ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. Its ENROUTE Transcarotid Stent System is placed during a period of temporary high-rate blood flow reversal, which is enabled by its ENROUTE Transcarotid NPS. It markets and sells its products in the United States through a direct sales organization consisting of approximately 64 sales representatives and 62 clinical support specialists.
|
|
|
|
| |
SILK's position in the Health Care Equipment & Supplies industry
| Industry Peers | MMSI | |
|---|---|---|
Summary | ||
| Company Profile | Silk Road Medical, Inc. is a medical device company, which is focused on reducing the risk of stroke and its devastating impact. The Company has discovered an approach for the treatment of carotid... | Merit Medical Systems, Inc. is a manufacturer and marketer of medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical... Go to MMSI summary |
| 52-Week Change | VS. INDUSTRY | 9.95% |
| Market Cap | VS. INDUSTRY | $4.1B |
| Beta | VS. INDUSTRY | 1.0 |
| Dividend Yield | VS. INDUSTRY | -- |
| P/E (TTM, GAAP) | VS. INDUSTRY | 55.08x |
| Data as of | ||
Fundamentals | ||
| Total Revenue (TTM) | VS. INDUSTRY | $1.2B |
| Profit Margin | VS. INDUSTRY | 6.47% |
| Earnings Growth (5 year, GAAP) | VS. INDUSTRY | 16.84% |
| Revenue Growth (TTM) | VS. INDUSTRY | 7.09% |
| Data as of |
Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.